Plante Moran Financial Advisors, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
Plante Moran Financial Advisors, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$7,000
+16.7%
1,7980.0%0.00%
+100.0%
Q2 2021$6,000
+50.0%
1,798
+5.9%
0.00%0.0%
Q1 2021$4,0000.0%1,6980.0%0.00%0.0%
Q4 2020$4,0000.0%1,698
+21.5%
0.00%0.0%
Q3 2020$4,0000.0%1,3980.0%0.00%
-50.0%
Q2 2020$4,000
+33.3%
1,3980.0%0.00%
+100.0%
Q1 2020$3,0000.0%1,398
+16.6%
0.00%0.0%
Q4 2019$3,000
-25.0%
1,1990.0%0.00%0.0%
Q3 2019$4,000
-42.9%
1,199
-33.4%
0.00%
-50.0%
Q2 2019$7,0001,7990.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
AMUSSEN HUNSAKER ASSOCIATES LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders